Pluri Inc banner

Pluri Inc
NASDAQ:PLUR

Watchlist Manager
Pluri Inc Logo
Pluri Inc
NASDAQ:PLUR
Watchlist
Price: 3.35 USD -3.76% Market Closed
Market Cap: $33.7m

Profitability Summary

Pluri Inc's profitability score is 47/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

47 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

47 / 100
Profitability
Score
47 / 100
Profitability
Score

Margins

Earnings Waterfall
Pluri Inc

Margins Comparison
Pluri Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IL
Pluri Inc
NASDAQ:PLUR
33.4m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
365.2B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
163.4B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
107.7B USD
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.1B USD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.3B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
60.2B AUD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Pluri Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
Pluri Inc
NASDAQ:PLUR
33.4m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
365.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
163.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
107.7B USD
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.1B USD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
60.2B AUD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Pluri Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett